{"disease":{"id":"pachychoroid-neovasculopathy","name":"pachychoroid neovasculopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05672979","title":"Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Yeungnam University College of Medicine","has_results":false},{"nct_id":"NCT05662410","title":"Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Kim's Eye Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}